Home » FDA Outlines Examples of Communications Consistent with Approved Labeling
FDA Outlines Examples of Communications Consistent with Approved Labeling
The FDA is providing industry with a list of examples of product communications, including promotional materials, consistent with agency-approved labeling.
Sponsors can disclose information on the safety and efficacy profile of a drug, including comparative and pivotal clinical trial data, to provide context consistent with FDA-required labeling. Information on adverse reactions, a drug’s effect in a subpopulation and the long-term safety and efficacy of a product are also considered appropriate disclosures.
The FDA said sponsors cannot convey information about unapproved uses. For example, a drugmaker should not characterize a therapy as a monotherapy if it is only approved for use in combination with another treatment.
Upcoming Events
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May